Full-Time

Biocompatibility Scientist

Posted on 11/23/2025

Deadline 11/30/25
GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Waukesha, WI, USA

Hybrid

Hybrid role; requires on-site presence in Waukesha, WI.

Category
Biology & Biotech (7)
, , , , , ,
Requirements
  • Bachelors Degree with 10+ years OR Master degree with 8+ OR PhD with 6+ years experience in physical/organic/biochemistry, toxicology, material science, bioengineering, or an equivalent scientific field.
  • Expert knowledge in use and application of ISO 10993 series of standards.
  • 6 years experience in design and development of medical devices that are categorized as FDA Class I, II and Class III.
  • Experience conducting material and chemical characterization of medical devices, physicochemical analyses of polymeric materials, metals, and ceramics.
  • Excellent verbal and written communication and presentation skills.
  • Advanced experience and proficiency with MS Office word processing, spreadsheet, presentation, and collaboration applications.
Responsibilities
  • Design and execute medical device biocompatibility strategies to assure user and patient safety through the application of current biological evaluation and toxicological principles in support of new product development and sustaining activities.
  • Standardize test methods across multiple material and device types, leveraging common data to derive meaningful conclusions on the potential for biocompatibility concern.
  • Lead and author Biocompatibility deliverables – e.g., biological evaluation plan & reports, hazard analysis, white paper, technical memo, and other relevant activities in support of global programs.
  • Implement the use of ISO 10993 series, 21CFR58 GLP for non-clinical studies, and/ or other regulatory guidance documents to qualify GE Healthcare products.
  • Provide technical and strategic input to meet business objectives at the project team level while assuring compliance with GE Healthcare and external standards.
  • Interpret raw material, finished device data, and literature to assess overall risk to patient.
  • Develop justification to address ISO 10993 – 1 endpoints based on study data and literature.
  • Independently review literature and identify relevant information to support product development and registration.
  • As needed – engage in standards organization and/ or regulatory committees to ensure emerging regulations are based on well-established science and toxicological principles.
  • Keep upto date on regulatory requirements and assess the impact of new standards and/or regulations to enable the generation of appropriate strategies for biocompatibility work.
Desired Qualifications
  • American Board of Toxicology Diplomate (DABT), or other national equivalent such as ERT.
  • Experience leading test lab operations that support medical device biocompatibility evaluations.
  • Experience in mechanical design (15+ years).
  • Experience as a lead convenor of a Technical Committee (TC) or Working Group (WG) of a Standards Development Organization (SDO) or National Standards Body (NSB) such as ISO, ANSI, or AAMI.
  • Experience preparing communications for and interacting with multiple regulatory bodies world-wide such as FDA, NMPA, TGA, MHLW, PMDA, CDSCO, BfArM, ANSM, etc.
  • Experience with high risk, life supporting, and life-sustaining products.
  • Demonstrated life-long learner; eagerness to obtain new skills and knowledge.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • DeepHealth partnership increases breast cancer detection by 21%, expanding AI-driven diagnostic revenue.
  • Photonova Spectra photon-counting CT processes 50x more data than conventional systems.
  • Record $21.8B backlog and $20.6B 2025 revenue demonstrate strong market demand.

What critics are saying

  • Memory chip inflation forces margin compression from 18% to 15% despite pricing actions.
  • Siemens Cios Alpha photon-counting C-arm captures 15-20% of GE's high-margin imaging share.
  • FDA delays Sonic DL 510(k) clearance beyond Q4 2026, blocking 85% speedup claims.

What makes GE Healthcare unique

  • SIGNA One AI ecosystem streamlines MRI workflows from planning through scanning and beyond.
  • Sonic DL deep-learning reconstruction enables up to 85% scan time reduction for MR exams.
  • SIGNA Sprint Freelium uses less than 1% helium, addressing sustainability and operational constraints.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE